Price:
Rs. 18,000.00
Sample Type: EDTA Blood
Fasting Not Required
Notes:H0810
Frequently Asked Questions (FAQ's):
What does the NextGen Hereditary Cancer Panel include?
It includes next-generation sequencing of multiple genes associated with hereditary cancers such as breast, ovarian, colorectal, and others.
How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses high-depth NGS technology with stringent validation to ensure accurate detection of pathogenic variants.
Who should take this test?
Individuals with a family history of cancer, early-onset cancers, or clinicians recommending genetic risk assessment may need this panel.
What sample is required for this test?
A blood sample collected in an EDTA vial is used for DNA extraction and analysis.
How do the results help in cancer prevention?
Results can identify inherited mutations, enabling timely surveillance, lifestyle modifications, and risk-reduction strategies.
Are the results reliable at Metropolis Healthcare?
Yes, Metropolis Healthcare follows global standards, expert analysis, and multi-step verification for dependable genetic reporting.
Can this test guide treatment decisions?
In some cases, inherited mutations can influence targeted therapies or surgical planning.
Why choose Metropolis Healthcare for hereditary cancer testing?
Because Metropolis Healthcare offers advanced genomic technology, precise interpretation, and trusted clinical support